Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients

ClinicalTrials.gov ID: NCT00105937

Public ClinicalTrials.gov record NCT00105937. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 8:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multi-center, Open Label, Long-term Study of OraVescent Fentanyl Citrate for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients

Study identification

NCT ID
NCT00105937
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cephalon
Industry
Enrollment
300 participants

Conditions and interventions

Conditions

Interventions

  • OraVescent fentanyl citrate Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2004
Primary completion
Not listed
Completion
Oct 31, 2006
Last update posted
Jun 28, 2012

2004 – 2006

United States locations

U.S. sites
43
U.S. states
22
U.S. cities
39
Facility City State ZIP Site status
Center for Pain Management Huntsville Alabama 35801
Outcomes Research International Tucson Arizona 85711
Arizona Clinical Research Center Tucson Arizona 85712
Hot Spring Pain Clinic Hot Springs Arkansas 71913
Saint Joseph's Mercy Cancer Center Hot Springs Arkansas 71913
Arkansas Cancer Institute Pine Bluff Arkansas 71603
City of Hope National Medical Center Duarte California 91010
The Cancer Prevention and Treatment Center Soquel California 95073
Northwestern Connecticut Oncology & Hematology Associates Torrington Connecticut 06790
Florida Institute of Medical Research Jacksonville Florida 32207
University of Florida Shands Cancer Center at Jacksonville Jacksonville Florida 32209
Hematology Oncology Associates Lake Worth Florida 33461-4710
Innovative Medical Research of South Florida Miami Shores Florida 33138
Gulf Coast Oncology Association St. Petersburg Florida 33705
Clinical Pharmacology Services, Inc Tampa Florida 33617
Palm Beach Research West Palm Beach Florida 33409
Florida Medical Clinic, PA Zephyrhills Florida 33542
Southeastern Gynecologic Oncology, LLC Atlanta Georgia 30342
North Shore Cancer Research Association Skokie Illinois 60076
Kentucky Cancer Clinic Hazard Kentucky 41701
Southwest Oncology Associates Lafayette Louisiana 70503
Hematology and Oncology Specialists New Orleans Louisiana 70115
St. Agnes Healthcare Baltimore Maryland 21229
Huron Medical Center Port Huron Michigan 48067
Providence Cancer Institute Southfield Michigan 48075
Bond Clinic, Inc Rolla Missouri 65407
HealthCare Research, LLC St Louis Missouri 63141
North Shore University Hospital Manhasset New York 11030
Beth Israel Medical Center New York New York 10003
The Center for Clinical Research, LLC Winston-Salem North Carolina 27103
PETC Research Group, Inc. Tulsa Oklahoma 74137
Oncology Associates of Oregon Eugene Oregon 97401
Allegheny Pain Management, PC Altoona Pennsylvania 16601
St. Mary Medical Center Langhorne Pennsylvania 19047
Mohamed Haq Pasadena Texas 77504
Cancer Care Centers of South Texas San Antonio Texas 78229
UTHCT (ATTN: Clinical Research) Tyler Texas 75708
Hunstman Cancer Institute Salt Lake City Utah 84112
Palliative Care and Pain Medicine Salt Lake City Utah 84157
Great Basin Clinical Research West Point Utah 84015
Cancer Outreach Associates, PC Abingdon Virginia 24211
MedSource Inc Richmond Virginia 23229
University of Wisconsin Medical School Madison Wisconsin 53792-5669

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00105937, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 28, 2012 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00105937 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →